Drug intelligence / Profile preview

duox2 siRNA

Development stage
Unknown
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Topical
01

Overview

Duox2 siRNA is a small interfering RNA (siRNA) designed to silence the expression of the Dual Oxidase 2 (DUOX2) gene. DUOX2 is an enzyme belonging to the NADPH oxidase family, primarily responsible for generating hydrogen peroxide (H2O2) at the apical surface of epithelial tissues and in macrophages. This H2O2 production is critical for oxidative host defense and inflammatory signaling. In experimental models, Duox2 siRNA has been used to demonstrate that DUOX2 is essential for house dust mite-induced cytokine production in keratinocytes and for the shedding of membrane-bound fractalkine in macrophages. It also plays a major role in basal H2O2 synthesis in airway epithelia. While currently utilized primarily as a research tool to study oxidative stress and innate immunity, it represents a potential therapeutic approach for modulating inflammatory diseases.

Other names
siRNA for DUOX2DUOX2-targeting siRNADUOX-2-targeting siRNADUOX 2-targeting siRNAsmall interfering RNA for DUOX2
02

Targets

NOX (NADPH oxidase)

Beyond the preview

Go deeper on duox2 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on duox2 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call